Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 1.16 --0 (-0%)
Previous Close $1.16    52 Week High
Open $1.16    52 Week Low
Day High $1.16    P/E N/A 
Day Low $1.16    EPS
Volume 51,820       

(NASDAQ: PLRZ) Delayed: 11.24 --0 (-0%)
Previous Close $11.24    52 Week High
Open $11.24    52 Week Low
Day High $11.24    P/E N/A 
Day Low $11.24    EPS
Volume 110